Sanofi to Buy Vigil Neuroscience for About $470 Million
Sanofi to acquire Vigil Neuroscience in $470 million deal
Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3
Vigil Neuroscience initiated with an Outperform at William Blair